FindTrial
Sign In

Dynamic systemic immune-inflammation index in predicting outcomes in acute ischemic stroke with intravenous thrombolysis

Dynamic systemic immune-inflammation index in predicting outcomes in acute ischemic stroke with intravenous thrombolysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073382
Enrollment
Unknown
Registered
2023-07-10
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Poor prognosis group after intravenous thrombolysis for stroke:None

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 105 Years

Inclusion criteria

Inclusion criteria: Complying with the relevant thrombolysis standards for rt-PA (0.9 mg/kg) in the 2018 Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke and receiving intravenous thrombolysis within 4.5 hours of onset; Performing bridging therapy; Having a complete medical history record; Obtaining informed consent of the patient or their legally authorized agent.

Exclusion criteria

Exclusion criteria: Concomitant severe mental disorders or dementia; Severe organ dysfunction such as heart, liver, and kidney; Malignant tumors; Acute myocardial infarction; Infectious and rheumatic immune diseases.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale;—

Secondary

MeasureTime frame
Montreal Cognitive Assessment;Hamilton Anxiety Scale;Hamilton Depression Scale;—

Countries

China

Contacts

Public ContactWen-jian Lin

Shanghai Tenth People's Hospital

2133169@tongji.edu.cn+86 188 8356 0800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026